Table 3.

Comparison of SELDI-TOF MS, ELISA, and SVM in the detection of bone metastasis in prostate cancer patients.1

AnalysisNo metastasesMetastases
SELDI-TOF MS10% (2/19)58% (11/19)
ELISA21% (4/19)84% (16/19)
SVM89.5% (34/38)